Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis
Introduction: The primary objective of the study was to evaluate the measurement properties of the patient-reported four-item Psoriasis Symptom Scale (PSS). Methods: Analysis of phase-III data on the efficacy of risankizumab to assess psychometric characteristics of the PSS in patients with moderate...
Main Authors: | Anne M. Rentz, Anne M. Skalicky, Dirk Esser, Carla Zema, Karin Becker, Amit Bodhani, Dennis A. Revicki |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1709612 |
Similar Items
-
The content validity of the PSS in patients with plaque psoriasis
by: A. M. Rentz, et al.
Published: (2017-09-01) -
Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses
by: April W. Armstrong, et al.
Published: (2020-07-01) -
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis
by: Paolo Gisondi, et al.
Published: (2021-10-01) -
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
by: Alice B. Gottlieb, et al.
Published: (2020-08-01) -
Stigmatization among Patients with Plaque Psoriasis
by: Barbara Jankowiak, et al.
Published: (2023-10-01)